PP2A prevents hyperphosphorylation of tau via the downregulation of several CNS Ser/Thr kinases involved in the pathogenesis of AD, including GSK-3β, JNK, and extracellular-regulated kinase (ERK) [71]. This evidence concerns the gene MAPT and Alzheimer disease.